Cargando…
Peripherally restricted transthyretin-based delivery system for probes and therapeutics avoiding opioid-related side effects
Several investigations into the sites of action of opioid analgesics have utilized peripherally acting mu-opioid receptor antagonists (PAMORAs), which have been incorrectly assumed to possess limited permeability across the blood-brain barrier. Unfortunately, the poor pharmacokinetic properties of c...
Autores principales: | Tuhin, Md Tariqul Haque, Liang, Dengpan, Liu, Fang, Aldawod, Hala, Amin, Toufiq Ul, Ho, Joshua S., Emara, Rasha, Patel, Arjun D., Felmlee, Melanie A., Park, Miki S., Uchizono, James A., Alhamadsheh, Mamoun M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9226319/ https://www.ncbi.nlm.nih.gov/pubmed/35739116 http://dx.doi.org/10.1038/s41467-022-31342-z |
Ejemplares similares
-
Hydrophilic Small Molecules That Harness Transthyretin
To Enhance the Safety and Efficacy of Targeted Chemotherapeutic Agents
por: Pal, Arindom, et al.
Publicado: (2019) -
Hydromorphone-Induced Tactile Hallucinations: Rare Opioid Side Effect
por: Kiyokawa, Miki, et al.
Publicado: (2021) -
Avoiding misdiagnosis: expert consensus recommendations for the suspicion and diagnosis of transthyretin amyloidosis for the general practitioner
por: Gertz, Morie, et al.
Publicado: (2020) -
Annual Cardiovascular-Related Hospitalization Days Avoided with Tafamidis in Patients with Transthyretin Amyloid Cardiomyopathy
por: Rozenbaum, Mark H., et al.
Publicado: (2022) -
Diagnostic challenges in hereditary transthyretin amyloidosis with polyneuropathy: avoiding misdiagnosis of a treatable hereditary neuropathy
por: Cortese, Andrea, et al.
Publicado: (2017)